Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
Clinical trial NCT04483739 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04483739
- Sponsor
- European Myeloma Network B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2025-07-31
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.